substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and bradykinin

substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- has been researched along with bradykinin in 2 studies

Compound Research Comparison

Studies (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)	Trials (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)	Recent Studies (post-2010) (substance p (6-11), arg(6)-trp(7,9)-me-phe(8)-)	Studies (bradykinin)	Trials (bradykinin)	Recent Studies (post-2010) (bradykinin)
20	0	1	14,195	355	1,520

Protein Interaction Comparison

Protein	Taxonomy	substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- (IC50)	bradykinin (IC50)
B2 bradykinin receptor	Homo sapiens (human)		0.0018

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Rozengurt, E; Woll, PJ	1
Cummings, J; Haslett, C; Jodrell, D; MacKinnon, AC; Sethi, T; Tufail-Hanif, U; Waters, CM	1

Other Studies

2 other study(ies) available for substance p (6-11), arg(6)-trp(7,9)-me-phe(8)- and bradykinin

Article	Year
A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro. Cancer research, 1990, Jul-01, Volume: 50, Issue:13 Topics: Animals; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; Cells, Cultured; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Peptide Fragments; Peptides; Recombinant Proteins; Substance P; Tumor Cells, Cultured; Vasopressins	1990
Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition. British journal of cancer, 2003, Jun-02, Volume: 88, Issue:11 Topics: Animals; Antineoplastic Agents; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fibroblasts; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptide Fragments; Rats; Receptors, Bombesin; Receptors, Neuropeptide; Substance P; Transplantation, Heterologous; Tumor Cells, Cultured; Vasopressins	2003

Article

Year

A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro.

Cancer research, 1990, Jul-01, Volume: 50, Issue:13

Topics: Animals; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; Cells, Cultured; DNA, Neoplasm; Drug Screening Assays, Antitumor; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Peptide Fragments; Peptides; Recombinant Proteins; Substance P; Tumor Cells, Cultured; Vasopressins

1990

Increased gastrin-releasing peptide (GRP) receptor expression in tumour cells confers sensitivity to [Arg6,D-Trp7,9,NmePhe8]-substance P (6-11)-induced growth inhibition.

British journal of cancer, 2003, Jun-02, Volume: 88, Issue:11

Topics: Animals; Antineoplastic Agents; Bradykinin; Calcium; Carcinoma, Small Cell; Cell Division; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Fibroblasts; Gastrin-Releasing Peptide; Humans; Lung Neoplasms; Mice; Mice, Nude; Peptide Fragments; Rats; Receptors, Bombesin; Receptors, Neuropeptide; Substance P; Transplantation, Heterologous; Tumor Cells, Cultured; Vasopressins

2003